Development of a unified patient flow model

Development of a unified patient flow model

Life Sciences

A global specialty pharmaceutical company sought to improve understanding of business opportunities underlying the patient flow for their rare disease franchises. The challenge was two-fold: identify areas for improvement in country-level patient finding excellence while creating a unified language and ongoing process across countries and franchises at the global level.

CRA approach

  • Development, together with the global franchise teams, of disease-specific patient flows and methodologies for their completion
  • Conduction of 30 live patient flow workshops and 20+ remote sessions:
  • Quantification of the patient flow
  • Identification of opportunities along the flow
  • Prioritization and quantification of opportunities
  • Development of a user-friendly Patient Flow toolkit for yearly refresh of the exercise, to be used by country teams​

Client impact